The store will not work correctly when cookies are disabled.
2-Methyl-N-phenethylimidazo[1,2-a]pyridine-3-carboxamide
ID: ALA3310313
PubChem CID: 67392765
Max Phase: Preclinical
Molecular Formula: C17H17N3O
Molecular Weight: 279.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2ccccn2c1C(=O)NCCc1ccccc1
Standard InChI: InChI=1S/C17H17N3O/c1-13-16(20-12-6-5-9-15(20)19-13)17(21)18-11-10-14-7-3-2-4-8-14/h2-9,12H,10-11H2,1H3,(H,18,21)
Standard InChI Key: NXSRMCPZIVTULI-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
11.0761 -2.9338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7906 -2.5213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7906 -1.6963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0761 -1.2838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3616 -1.6963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3616 -2.5213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9046 -3.7408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0841 -3.8270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7485 -3.0733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9416 -2.9018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6866 -2.1172 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3582 -3.4852 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5613 -3.2716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9779 -3.8550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1811 -3.6415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5977 -4.2248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8008 -4.0113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5873 -3.2144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1706 -2.6311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9675 -2.8446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6716 -4.5415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 1 0
7 8 1 0
8 9 2 0
6 9 1 0
1 7 2 0
10 11 2 0
10 12 1 0
9 10 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
12 13 1 0
8 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 279.34 | Molecular Weight (Monoisotopic): 279.1372 | AlogP: 2.62 | #Rotatable Bonds: 4 |
Polar Surface Area: 46.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.47 | CX LogP: 1.90 | CX LogD: 1.90 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.80 | Np Likeness Score: -1.87 |
References
1. Samala G, Nallangi R, Devi PB, Saxena S, Yadav R, Sridevi JP, Yogeeswari P, Sriram D.. (2014) Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors., 22 (15): [PMID:24953948] [10.1016/j.bmc.2014.05.038] |